PEMF therapy vs. leg compression for blood clot prevention in ICU
Part of Heart & circulation clinical trials.
This trial is testing two different ways to prevent dangerous blood clots in ICU patients who cannot take blood-thinning medication. It compares a pulsed electromagnetic field device (PEMF) to a standard leg compression device. Both treatments are non-invasive and used without medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and currently in the intensive care unit (ICU).
- You are at high risk for blood clots (based on a standard scoring system).
- You cannot take blood-thinning medication, or you need both medication and a mechanical device to prevent blood clots.
- You do not have leg injuries, burns, fractures, or other problems that would prevent using a mechanical compression device.
- You are expected to live more than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This study tests whether a blood thinner (LMWH) can help prevent dangerous blood clots in teens with a central line and infection or inflammation in the pediatric intensive care unit (PICU). It aims to find a safer, more personalized way to use preventive treatment.
This study tests two experimental drugs, REGN7508 and REGN9933, to see if they can safely prevent blood clots in the arm or chest in people who need a PICC line. If you are getting a PICC for treatments like chemotherapy or antibiotics, you may be able to join.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.